US Stocks
/
Neuphoria Therapeutics Inc. Share Price

Neuphoria Therapeutics Inc. Share Price

NASDAQ: NEUP | Micro Cap
$3.42
-$0.02 (-0.58%) Last updated on 08 Oct, 2026 | 01:20 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Neuphoria Therapeutics Inc. Stock Performance

Open
$3.42
Prev. Close
$3.44
Circuit Range
N/A
Day Range
$3.42 - $3.42
Year Range
$3.31 - $20.65
Volume
114
Average Traded
$3.42

Neuphoria Therapeutics Inc. Share Price Today

As of 10 October 2026, Neuphoria Therapeutics Inc.'s share price is $3.42. The stock opened at $3.42, compared to its previous close of $3.44. During today's trading session, Neuphoria Therapeutics Inc.'s share price traded between $3.42 and $3.42, with an average price of $3.42. Over the past 52 weeks, the stock has recorded a high of $20.65 and a low of $3.31. In terms of performance, Neuphoria Therapeutics Inc.'s share price has declined by 35.83% over the last six months and is down 24.84% on a year-on-year basis.

Neuphoria Therapeutics Inc. Share Price Chart

$3.42$3.42
L
Show Current Price
H

Neuphoria Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.55M
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company focused on therapies for serious central nervous system disorders. Its lead product candidate, BNC210, is an oral, proprietary, selective negative allosteric modulator of the alpha7 nicotinic acetylcholine receptor. The company has discontinued development of BNC210 for social anxiety disorder, while its BNC210 program for post-traumatic stress disorder is currently paused and no active clinical trial is underway. The company operates through a single operating and reporting segment focused on the discovery and development of allosteric ion-channel modulators for serious CNS disorders with high unmet medical need.

Neuphoria Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$3.52
$3.42
-3.39%
Sep 2026
$3.80
$3.54
-6.35%
Aug 2026
$3.94
$3.78
-3.32%
Jul 2026
$4.51
$3.91
-11.74%
Jun 2026
$5.27
$4.43
-15.62%
May 2026
$5.29
$5.25
-1.50%
Apr 2026
$4.21
$5.33
+30.96%
Mar 2026
$4.33
$4.07
-2.63%
Feb 2026
$4.02
$4.18
+4.76%
Jan 2026
$3.88
$3.99
+4.45%
Dec 2025
$4.43
$3.82
-15.11%
Nov 2025
$4.53
$4.50
-1.10%

NEUP Share Price FAQs

What is Neuphoria Therapeutics Inc. share price today?

chevron-up
Neuphoria Therapeutics Inc. share price today is $3.42 as on October 8, 2026 at 1:20 am IST.

What is the 52 week high and 52 week low of Neuphoria Therapeutics Inc. stock?

chevron-up
The 52 week high of Neuphoria Therapeutics Inc. stock is $20.65, while the 52 week low is $3.31 as of 8 Oct '26.

What is NEUP's market capitalisation today?

chevron-up
NEUP market capitalisation is $5.55M as of October 10, 2026, at 4:42 am IST.

What is the 5 year returns of NEUP?

chevron-up
The 5 year returns of NEUP is -72.75% as on 8 Oct '26.

What is the high & low stock price of NEUP today?

chevron-up
NEUP stock price hit a high of $3.42 and low of $3.42 as of 8 Oct '26.

Can I buy NEUP shares in India?

chevron-up
Yes. You can buy NEUP in India by opening an international trading account.